{
    "nctId": "NCT04597580",
    "briefTitle": "Personalised Disease Monitoring in Metastatic Breast Cancer",
    "officialTitle": "Personalised Disease Monitoring During Treatment With an Aromatase Inhibitor + Cyclin Dependent Kinase (CDK) 4/6 Inhibitor as 1st Line Endocrine Therapy in Patients With ER-positive/HER2-negative Metastatic Breast Cancer",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer Metastatic, Estrogen Receptor-positive Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 97,
    "primaryOutcomeMeasure": "Change in blood levels of ctDNA, CA15-3 and TK-1 assays from baseline to disease progression",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Advanced breast cancer\n* ER-positive/HER2-negative\n* For patients who have had a prior non-breast malignancy within the last 5 years (excluding in situ carcinoma of the cervix and basal cell carcinoma of the skin) biopsy of a metastatic site is required to confirm the diagnosis of metastatic ER+/HER2- breast cancer.\n* Eligible for 1st line endocrine therapy with an aromatase inhibitor and a CDK4/6 inhibitor\n* Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0-2\n* Age \u2265 18 years\n* Life expectancy \\> 3 months\n* Radiologically assessable disease\n\nExclusion Criteria:\n\n* Known central nervous system (CNS) metastases, carcinomatous meningitis or leptomeningeal disease unless treated with radiotherapy and symptomatically stable at least 2 weeks after discontinuation of steroids\n* Concurrent disease(s) or familial, sociological or geographical condition that would, in the investigator's opinion, preclude compliance with study procedures\n* Any serious medical disorder that would compromise the patient's safety\n* Dementia, altered mental status, or any psychiatric condition that would prevent the understanding or rendering of Informed Consent",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}